Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 38NIH 4OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Liver Neoplasms 1Hepatitis B 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

tislelizumab 4Sorafenib 3Propranolol 3ledipasvir 2entecavir 2donafenib 2apatinib 2Sofosbuvir 2Ribavirin 2Radiotherapy 2Proton Therapy 2Bevacizumab 2sitravatinib 1polysaccharide MGN3 1palbociclib 1lenvatinib 1lens intermediate filament proteins 1ledipasvir, sofosbuvir drug combination 1envafolimab 1elbasvir-grazoprevir drug combination 1daclatasvir 1camrelizumab 1atezolizumab 1anlotinib 1Vitamin D 1Urination 1Tyrosine Kinase Inhibitors 1Surgical Procedures, Operative 1Simeprevir 1Raltegravir Potassium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Carcinoma, Hepatocellular × Radiofrequency Ablation × Clear all
NCT01018381 2009-11-23

Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection

The 108 Military Central Hospital

Phase NA Completed
130 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡